News
-
-
PRESS RELEASE
Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026
Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026 with sales revenue up 7.9% in constant currencies. Profitability remains strong with a margin of 30.7% and net profit of 88 million euros -
-
-
-
-
-
-
PRESS RELEASE
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
Resolutions of the Combined Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A. Shareholders grant discharge to all Directors, approve dividend payout, and announce Board of Directors composition -